Provider QP93-22 MHCP Pharmacy Benefit Exclusion for Pedmark®, Rolvedon™, Skysona®, Spevigo®, and Xenpozyme™ Read More
Provider QP96-22 Update: Change to 2023 Cyber Insurance Requirement for Primary Care Clinic and Institutional Providers Read More
Provider QP91-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2023 Read More
